Yahoo
NasdaqGM - Nasdaq Real Time Price USD

CRISPR Therapeutics AG (CRSP)

50.07 +1.51 (+3.11%)
At close: November 6 at 4:00:01 PM EST
49.35 -0.72 (-1.44%)
After hours: 7:40:13 PM EST
Trade CRSP on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
23,323
0
35,000
370,000
436
Cost of Revenue
181,208
213,480
120,667
130,250
110,250
Gross Profit
-157,885
-213,480
-85,667
239,750
-109,814
Operating Expense
360,293
354,838
380,899
462,288
563,347
Operating Income
-518,178
-568,318
-466,566
-222,538
-673,161
Other Income Expense
64,530
-9,647
103,901
71,816
22,661
Pretax Income
-453,648
-577,965
-362,665
-150,722
-650,500
Tax Provision
2,487
3,634
3,587
2,888
-325
Net Income Common Stockholders
-456,135
-581,599
-366,252
-153,610
-650,175
Diluted NI Available to Com Stockholders
-456,135
-581,599
-366,252
-153,610
-650,175
Basic EPS
-4.73
-6.47
-4.34
-1.94
-8.36
Diluted EPS
-4.73
-6.47
-4.34
-1.94
-8.36
Basic Average Shares
96,160.42
89,925.11
84,359.13
79,220.93
77,746.58
Diluted Average Shares
96,160.42
89,925.11
84,359.13
79,220.93
77,746.58
Total Operating Income as Reported
-532,326
-664,571
-466,566
-222,538
-673,161
Total Expenses
541,501
568,318
501,566
592,538
673,597
Net Income from Continuing & Discontinued Operation
-456,135
-581,599
-366,252
-153,610
-650,175
Normalized Income
-447,646.20
-504,221.21
-366,252
-153,610
-650,175
EBIT
-518,178
-568,318
-466,566
-222,538
-673,161
EBITDA
-499,680
-548,839
-447,307
-202,701
-648,989
Reconciled Cost of Revenue
181,208
213,480
120,667
130,250
110,250
Reconciled Depreciation
18,498
19,479
19,259
19,837
24,172
Net Income from Continuing Operation Net Minority Interest
-456,135
-581,599
-366,252
-153,610
-650,175
Total Unusual Items Excluding Goodwill
-14,148
-96,253
0
0
--
Total Unusual Items
-14,148
-96,253
0
0
--
Normalized EBITDA
-485,532
-452,586
-447,307
-202,701
-648,989
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,659.20
-18,875.21
0
0
0
12/31/2022 - 10/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: